Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

Abstract Background In patients with amyloid-positive mild cognitive impairment (MCI), neurodegenerative biomarkers such as medial temporal lobe atrophy (MTA) are useful to predict disease progression to dementia. Although posterior atrophy (PA) is a well-known neurodegenerative biomarker of Alzheim...

Full description

Bibliographic Details
Main Authors: Jung-Min Pyun, Young Ho Park, Hang-Rai Kim, Jeewon Suh, Min Ju Kang, Beom Joon Kim, Young Chul Youn, Jae-Won Jang, SangYun Kim, the Alzheimer’s Disease Neuroimaging Initiative
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Posterior atrophy
Biomarkers
Disease progression
Mild cognitive impairment
Alzheimer’s disease
Online Access:http://link.springer.com/article/10.1186/s13195-017-0326-y

Internet

http://link.springer.com/article/10.1186/s13195-017-0326-y

Similar Items